Remus Pharmaceuticals Ltd
NSE: REMUS BSE: 78788
₹746.90
(4.40%)
Wed, 13 May 2026, 07:07 am
Market Cap8.43B
PE Ratio26.26
Dividend0.14
Health Technology
Pharmaceuticals: Major
24.5KRemus Pharmaceuticals Financials
| Particulars | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Total revenue | 119.19M | 184.18M | 247.04M | 450.27M | 2.13B | 6.20B |
| Gross profit | 19.14M | 37.54M | 79.17M | 166.60M | 398.00M | 708.60M |
| Operating expenses (excl. COGS) | -14.79M | -29.80M | -36.91M | -60.78M | -118.40M | -267.80M |
| Selling/general/admin expenses, total | -16.27M | -31.67M | -37.70M | -65.61M | -118.40M | -267.70M |
| Research & development | -73.00K | -8.00K | -23.00K | -180.00K | -200.00K | 0 |
| Selling/general/admin expenses, other | -16.20M | -31.66M | -37.67M | -65.43M | -118.20M | -267.70M |
| Other operating expenses, total | 1.49M | 1.86M | 785.00K | 4.83M | 0 | -100.00K |
| Operating income | 4.36M | 7.73M | 42.26M | 105.82M | 279.60M | 440.80M |
| Non-operating income, total | 6.58M | 5.85M | 3.88M | 8.32M | 22.10M | 32.60M |
| Interest expense, net of interest capitalized | -227.00K | -332.00K | -312.00K | -1.10M | -5.00M | -14.60M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | 6.81M | 6.18M | 4.19M | 9.42M | 27.10M | 47.20M |
| Non-operating interest income | 0 | 672.00K | 2.43M | 3.44M | 22.30M | 22.10M |
| Miscellaneous non-operating expense | 6.81M | 5.51M | 1.76M | 5.98M | 4.80M | 25.10M |
| Unusual income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Pretax income | 10.94M | 13.58M | 46.13M | 114.14M | 301.70M | 473.40M |
| Taxes | -2.82M | -3.32M | -11.79M | -29.11M | -58.90M | -89.20M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | -37.60M | -93.50M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 8.12M | 10.26M | 34.34M | 85.03M | 205.20M | 290.70M |
| Net income | 8.12M | 10.26M | 34.34M | 85.03M | 205.20M | 290.70M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 8.12M | 10.26M | 34.34M | 85.03M | 205.20M | 290.70M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - |
| EBITDA | 5.42M | 9.48M | 43.80M | 110.59M | 290.80M | 459.50M |
| EBIT | 4.36M | 7.73M | 42.26M | 105.82M | 279.60M | 440.80M |
| Total operating expenses | -114.83M | -176.45M | -204.79M | -344.45M | -1.85B | -5.76B |
| Prepaid expenses | — | — | 73.00K | 490.00K | 400.00K | 3.20M |
| Deferred income, current | 13.28M | 11.24M | 36.71M | 22.41M | 358.60M | 279.80M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 16.60M | 16.60M |
| Operating lease liabilities | — | — | — | — | — | — |
| Deferred tax liabilities | — | — | — | — | 111.60M | 229.00M |
| Deferred income, non-current | — | — | — | — | — | — |
| Minority interest | 0 | 0 | 0 | 0 | 175.20M | 266.90M |
| Change in accrued expenses | — | — | — | — | — | — |
| Common dividends paid | 0 | 0 | 0 | 0 | -5.90M | -11.80M |
| Preferred dividends paid | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800